[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Leiomyosarcoma Drug Market Report 2018

March 2018 | 103 pages | ID: U1843C7A514QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Leiomyosarcoma Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Leiomyosarcoma Drug in these regions, from 2013 to 2025 (forecast).
United States Leiomyosarcoma Drug market competition by top manufacturers/players, with Leiomyosarcoma Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Advenchen Laboratories, LLC
  • BeiGene, Ltd.
  • Cell Medica Limited
  • Karyopharm Therapeutics, Inc.
  • Merck & Co., Inc.
  • Mirati Therapeutics Inc.
  • Novartis AG
  • Vicore Pharma AB
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • AL-3818
  • BGB-290
  • C-21
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Leiomyosarcoma Drug Market Report 2018

1 LEIOMYOSARCOMA DRUG OVERVIEW

1.1 Product Overview and Scope of Leiomyosarcoma Drug
1.2 Classification of Leiomyosarcoma Drug by Product Category
  1.2.1 United States Leiomyosarcoma Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Leiomyosarcoma Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 AL-3818
  1.2.4 BGB-290
  1.2.5 C-21
  1.2.6 Others
1.3 United States Leiomyosarcoma Drug Market by Application/End Users
  1.3.1 United States Leiomyosarcoma Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 United States Leiomyosarcoma Drug Market by Region
  1.4.1 United States Leiomyosarcoma Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Leiomyosarcoma Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Leiomyosarcoma Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Leiomyosarcoma Drug Status and Prospect (2013-2025)
  1.4.5 New England Leiomyosarcoma Drug Status and Prospect (2013-2025)
  1.4.6 The South Leiomyosarcoma Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Leiomyosarcoma Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Leiomyosarcoma Drug (2013-2025)
  1.5.1 United States Leiomyosarcoma Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Leiomyosarcoma Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES LEIOMYOSARCOMA DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Leiomyosarcoma Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Leiomyosarcoma Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Leiomyosarcoma Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Leiomyosarcoma Drug Market Competitive Situation and Trends
  2.4.1 United States Leiomyosarcoma Drug Market Concentration Rate
  2.4.2 United States Leiomyosarcoma Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Leiomyosarcoma Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LEIOMYOSARCOMA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Leiomyosarcoma Drug Sales and Market Share by Region (2013-2018)
3.2 United States Leiomyosarcoma Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Leiomyosarcoma Drug Price by Region (2013-2018)

4 UNITED STATES LEIOMYOSARCOMA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Leiomyosarcoma Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Leiomyosarcoma Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Leiomyosarcoma Drug Price by Type (2013-2018)
4.4 United States Leiomyosarcoma Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES LEIOMYOSARCOMA DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Leiomyosarcoma Drug Sales and Market Share by Application (2013-2018)
5.2 United States Leiomyosarcoma Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES LEIOMYOSARCOMA DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Advenchen Laboratories, LLC
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Leiomyosarcoma Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Advenchen Laboratories, LLC Leiomyosarcoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 BeiGene, Ltd.
  6.2.2 Leiomyosarcoma Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 BeiGene, Ltd. Leiomyosarcoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Cell Medica Limited
  6.3.2 Leiomyosarcoma Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cell Medica Limited Leiomyosarcoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Karyopharm Therapeutics, Inc.
  6.4.2 Leiomyosarcoma Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Merck & Co., Inc.
  6.5.2 Leiomyosarcoma Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck & Co., Inc. Leiomyosarcoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Mirati Therapeutics Inc.
  6.6.2 Leiomyosarcoma Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Mirati Therapeutics Inc. Leiomyosarcoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Novartis AG
  6.7.2 Leiomyosarcoma Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis AG Leiomyosarcoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Vicore Pharma AB
  6.8.2 Leiomyosarcoma Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Vicore Pharma AB Leiomyosarcoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview

7 LEIOMYOSARCOMA DRUG MANUFACTURING COST ANALYSIS

7.1 Leiomyosarcoma Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Leiomyosarcoma Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Leiomyosarcoma Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Leiomyosarcoma Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LEIOMYOSARCOMA DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Leiomyosarcoma Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Leiomyosarcoma Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Leiomyosarcoma Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Leiomyosarcoma Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Leiomyosarcoma Drug
Figure United States Leiomyosarcoma Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Leiomyosarcoma Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure AL-3818 Product Picture
Figure BGB-290 Product Picture
Figure C-21 Product Picture
Figure Others Product Picture
Figure United States Leiomyosarcoma Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Leiomyosarcoma Drug by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Leiomyosarcoma Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Leiomyosarcoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Leiomyosarcoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Leiomyosarcoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Leiomyosarcoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Leiomyosarcoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Leiomyosarcoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Leiomyosarcoma Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Leiomyosarcoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Leiomyosarcoma Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Leiomyosarcoma Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Leiomyosarcoma Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Leiomyosarcoma Drug Sales Share by Players/Suppliers
Figure 2017 United States Leiomyosarcoma Drug Sales Share by Players/Suppliers
Figure United States Leiomyosarcoma Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Leiomyosarcoma Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Leiomyosarcoma Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Leiomyosarcoma Drug Revenue Share by Players/Suppliers
Figure 2017 United States Leiomyosarcoma Drug Revenue Share by Players/Suppliers
Table United States Market Leiomyosarcoma Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Leiomyosarcoma Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Leiomyosarcoma Drug Market Share of Top 3 Players/Suppliers
Figure United States Leiomyosarcoma Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Leiomyosarcoma Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Leiomyosarcoma Drug Product Category
Table United States Leiomyosarcoma Drug Sales (K Pcs) by Region (2013-2018)
Table United States Leiomyosarcoma Drug Sales Share by Region (2013-2018)
Figure United States Leiomyosarcoma Drug Sales Share by Region (2013-2018)
Figure United States Leiomyosarcoma Drug Sales Market Share by Region in 2017
Table United States Leiomyosarcoma Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Leiomyosarcoma Drug Revenue Share by Region (2013-2018)
Figure United States Leiomyosarcoma Drug Revenue Market Share by Region (2013-2018)
Figure United States Leiomyosarcoma Drug Revenue Market Share by Region in 2017
Table United States Leiomyosarcoma Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Leiomyosarcoma Drug Sales (K Pcs) by Type (2013-2018)
Table United States Leiomyosarcoma Drug Sales Share by Type (2013-2018)
Figure United States Leiomyosarcoma Drug Sales Share by Type (2013-2018)
Figure United States Leiomyosarcoma Drug Sales Market Share by Type in 2017
Table United States Leiomyosarcoma Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Leiomyosarcoma Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Leiomyosarcoma Drug by Type (2013-2018)
Figure Revenue Market Share of Leiomyosarcoma Drug by Type in 2017
Table United States Leiomyosarcoma Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Leiomyosarcoma Drug Sales Growth Rate by Type (2013-2018)
Table United States Leiomyosarcoma Drug Sales (K Pcs) by Application (2013-2018)
Table United States Leiomyosarcoma Drug Sales Market Share by Application (2013-2018)
Figure United States Leiomyosarcoma Drug Sales Market Share by Application (2013-2018)
Figure United States Leiomyosarcoma Drug Sales Market Share by Application in 2017
Table United States Leiomyosarcoma Drug Sales Growth Rate by Application (2013-2018)
Figure United States Leiomyosarcoma Drug Sales Growth Rate by Application (2013-2018)
Table Advenchen Laboratories, LLC Basic Information List
Table Advenchen Laboratories, LLC Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Advenchen Laboratories, LLC Leiomyosarcoma Drug Sales Growth Rate (2013-2018)
Figure Advenchen Laboratories, LLC Leiomyosarcoma Drug Sales Market Share in United States (2013-2018)
Figure Advenchen Laboratories, LLC Leiomyosarcoma Drug Revenue Market Share in United States (2013-2018)
Table BeiGene, Ltd. Basic Information List
Table BeiGene, Ltd. Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure BeiGene, Ltd. Leiomyosarcoma Drug Sales Growth Rate (2013-2018)
Figure BeiGene, Ltd. Leiomyosarcoma Drug Sales Market Share in United States (2013-2018)
Figure BeiGene, Ltd. Leiomyosarcoma Drug Revenue Market Share in United States (2013-2018)
Table Cell Medica Limited Basic Information List
Table Cell Medica Limited Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cell Medica Limited Leiomyosarcoma Drug Sales Growth Rate (2013-2018)
Figure Cell Medica Limited Leiomyosarcoma Drug Sales Market Share in United States (2013-2018)
Figure Cell Medica Limited Leiomyosarcoma Drug Revenue Market Share in United States (2013-2018)
Table Karyopharm Therapeutics, Inc. Basic Information List
Table Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Sales Growth Rate (2013-2018)
Figure Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Sales Market Share in United States (2013-2018)
Figure Karyopharm Therapeutics, Inc. Leiomyosarcoma Drug Revenue Market Share in United States (2013-2018)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. Leiomyosarcoma Drug Sales Growth Rate (2013-2018)
Figure Merck & Co., Inc. Leiomyosarcoma Drug Sales Market Share in United States (2013-2018)
Figure Merck & Co., Inc. Leiomyosarcoma Drug Revenue Market Share in United States (2013-2018)
Table Mirati Therapeutics Inc. Basic Information List
Table Mirati Therapeutics Inc. Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Mirati Therapeutics Inc. Leiomyosarcoma Drug Sales Growth Rate (2013-2018)
Figure Mirati Therapeutics Inc. Leiomyosarcoma Drug Sales Market Share in United States (2013-2018)
Figure Mirati Therapeutics Inc. Leiomyosarcoma Drug Revenue Market Share in United States (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis AG Leiomyosarcoma Drug Sales Growth Rate (2013-2018)
Figure Novartis AG Leiomyosarcoma Drug Sales Market Share in United States (2013-2018)
Figure Novartis AG Leiomyosarcoma Drug Revenue Market Share in United States (2013-2018)
Table Vicore Pharma AB Basic Information List
Table Vicore Pharma AB Leiomyosarcoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Vicore Pharma AB Leiomyosarcoma Drug Sales Growth Rate (2013-2018)
Figure Vicore Pharma AB Leiomyosarcoma Drug Sales Market Share in United States (2013-2018)
Figure Vicore Pharma AB Leiomyosarcoma Drug Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Leiomyosarcoma Drug
Figure Manufacturing Process Analysis of Leiomyosarcoma Drug
Figure Leiomyosarcoma Drug Industrial Chain Analysis
Table Raw Materials Sources of Leiomyosarcoma Drug Major Players/Suppliers in 2017
Table Major Buyers of Leiomyosarcoma Drug
Table Distributors/Traders List
Figure United States Leiomyosarcoma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Leiomyosarcoma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Leiomyosarcoma Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Leiomyosarcoma Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Leiomyosarcoma Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Leiomyosarcoma Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Leiomyosarcoma Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Leiomyosarcoma Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Leiomyosarcoma Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Leiomyosarcoma Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Leiomyosarcoma Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Leiomyosarcoma Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Leiomyosarcoma Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories